AXSM Past Earnings image   This AXSM past earnings page last updated 10/7/2024
AXSM Past Earnings
PeriodPast Earnings DateAdj. EPS
Q2 20248/5/2024-1.120
Q1 20245/6/2024-1.000
Q4 20232/20/2024-0.730
Q3 202311/6/2023-1.320
Q2 20238/7/2023-1.540
Q1 20235/8/2023-0.260
Q4 20222/27/2023-1.410
Q3 202211/7/2022-1.070
Q2 20228/9/2022-1.060
Q1 20225/2/2022-1.030
Q4 20213/1/2022-0.900
Q3 202111/8/2021-0.930
Q2 20218/9/2021-0.860
Q1 20215/10/2021-0.780
Q4 20203/1/2021-0.780
Q3 202011/5/2020-0.610
Q2 20208/10/2020-0.490
Q1 20205/8/2020-0.880
Q4 20193/12/2020-0.710
Q3 201911/7/2019-0.560
Q2 20198/8/2019-0.410
Q1 20195/9/2019-0.320
Q4 20183/14/2019-0.32
Q3 201811/9/2018-0.31
Q2 20188/8/2018-0.32
Q1 20185/8/2018-0.19
Q4 20173/7/2018-0.31
Q3 201711/8/2017-0.27
Q2 20178/9/2017-0.3
Q1 20175/9/2017-0.41
Q4 20163/7/2017-0.38
Q3 201611/14/2016-0.38
Q2 20168/9/2016-0.36
Q1 20165/11/2016-0.31
Q4 20153/24/2016-0.12
AXSM Past Revenue
PeriodPast Earnings DateGAAP
Q2 20248/5/20240.09B
Q1 20245/6/20240.07B
Q4 20232/20/20240.07B
Q3 202311/6/20230.06B
Q2 20238/7/20230.05B
Q1 20235/8/20230.09B
Q4 20222/27/20230.02B
Q3 202211/7/20220.02B
Q2 20228/9/20220.01B
Q1 20225/2/2022NA
Q4 20213/1/2022NA
Q3 202111/8/2021NA
Q2 20218/9/2021NA
Q1 20215/10/2021NA
Q4 20203/1/2021NA
Q3 202011/5/2020NA
Q2 20208/10/2020NA
Q1 20205/8/2020NA
Q4 20193/12/2020NA
Q3 201911/7/2019NA
Q2 20198/8/2019NA
Q1 20195/9/2019NA
Q4 20183/14/2019NA
Q3 201811/9/2018NA
Q2 20188/8/2018NA
Q1 20185/8/2018NA
Q4 20173/7/2018NA
Q3 201711/8/2017NA
Q2 20178/9/2017NA
Q1 20175/9/2017NA
Q4 20163/7/2017NA
Q3 201611/14/2016NA
Q2 20168/9/2016NA
Q1 20165/11/2016NA
Q4 20153/24/2016NA
Quotes delayed 20 minutes

Email EnvelopeFree AXSM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Axsome Therapeutics (AXSM) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

AYTU Past Earnings
AZRX Past Earnings
AZYO Past Earnings
BACK Past Earnings
BAX Past Earnings
BBI Past Earnings
BBIO Past Earnings
BBLG Past Earnings
BCAB Past Earnings
BCDA Past Earnings

AXSM Past Earnings Q&A

What was the best and worst AXSM past earnings results?
For Axsome Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest AXSM past earnings result in our data set was -0.12/share posted in Q4 2015, while the lowest was in Q2 2023 when AXSM posted -1.540/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2023 when AXSM reported 0.09B in revenue, while the quarter with the lowest revenue in our data set was Q1 2022 at NA of revenue.

  Suggested answer: There are 35 AXSM past earnings results in our data set.

On this page we presented the AXSM past earnings date information for Axsome Therapeutics. Reviewing that AXSM Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2015, when AXSM posted adjusted EPS of -0.12/share. Meanwhile the lowest AXSM past earnings result was in Q2 2023, when AXSM posted adjusted EPS of -1.540/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2023 when AXSM reported 0.09B in revenue, while the smallest revenue quarter was Q1 2022 when AXSM reported NA in revenue.

Any self directed investor doing their due diligence on AXSM or any other given stock can benefit from researching all of the Axsome Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Axsome Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for AXSM. Thanks for visiting, and the next time you need to research AXSM past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Institutional Holders of AQ, Funds Holding ALD, RELV Split History.

 

AXSM Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.